MedTrace Logo

Comparison of Hemostatic Matrix and Bipolar Coagulation in Surgical Treatment of Endometriomas

NCT01268930 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2011-06-22

No results posted yet for this study

Summary

In this study, impacts of hemostatic matrix and bipolar electrocoagulation on ovarian reserve in women undergoing ovarian endometrioma excision are compared.

Conditions

  • Ovarian Reserve
  • Endometrioma

Interventions

PROCEDURE

Bipolar electrocautery for ovarian hemostasis

after surgical excision of ovarian endometrioma with cyst wall, bipolar electrocoagulation is used to control of bleeding.

PROCEDURE

hemostatic matrix (FloSeal)

after surgical excision of ovarian endometrioma with cyst wall, hemostatic matrix is administered to the bed of cyst for 2-3 minutes to control of bleeding. Then, area is rinsed and hemostasis is checked.

Sponsors & Collaborators

  • Ankara University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2011-02-28
Completion
2011-03-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01268930 on ClinicalTrials.gov